Enveric Biosciences receives U.S. patent for EVM301 molecules
#Enveric Biosciences #EVM301 #U.S. patent #molecules #biotech #intellectual property #pharmaceuticals
📌 Key Takeaways
- Enveric Biosciences secured a U.S. patent for its EVM301 molecules.
- The patent covers novel molecules developed by the company.
- This intellectual property protection strengthens Enveric's portfolio.
- The EVM301 molecules are part of Enveric's research and development efforts.
🏷️ Themes
Biotechnology, Intellectual Property
Entity Intersection Graph
No entity connections available yet for this article.